2016 08 09 - S&O Agenda - Item 8, Att 2 - AEC Noosa Convention & Performing Arts Centre Pre-feasibility Review

PRE-FEASIBILITY OF CONVENTION AND PERFORMING ARTS CENTRES


Figure E.1. Operating Surplus Ratio, No External Funding

    4%

    2%

    0%

    -2%

    -4%
            2016    2017 2018 2019 2020 2021 2022 2023 2024 2025
                         Operating Surplus Ratio After Proposal

Source: Council, AEC.

Under the extremely optimistic funding scenario, with two-thirds funded by the Queensland and Federal
Governments, the proposal still has a significant influence on Council’s operating position.

Figure E.2. Operating Surplus Ratio, $20 Million External Funding

    4%

    2%

    0%

    -2%

    -4%
            2016    2017 2018 2019 2020 2021 2022 2023 2024 2025
                         Operating Surplus Ratio After Proposal

Source: Council, AEC.

These financial outcomes exclude any allowance for required upgrades to supporting infrastructure and services
surrounding the proposed site.


ECONOMIC ASSESSMENT
Economic impacts to the Noosa Local Government Area (LGA) have been assessed during construction and once
operational.

During the construction phase the development is estimated to deliver the following economic impacts to the Noosa
LGA:

    $25.0 million in additional output (including $15.0 million directly).

    $9.2 million in GVA (including $4.6 million directly).

    $5.1 million in incomes and salaries paid to households (including $2.4 million directly).

    60 FTE jobs (including 28 directly).

Once fully operational, the convention centre and PAC facilities are estimated to generate in an ongoing annual
basis:

    $9.9 million in additional output (including $6.7 million directly).

    $4.5 million in GVA (including $2.9 million directly).

    $3.0 million in incomes and salaries paid to households (including $2.1 million directly).

    53 FTE jobs (including 41 directly).




                                                                                                               iv